Regional differentiation in the rat aorta: Effects of cyclooxygenase inhibitors

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 273, Issue 3 42-3, 1997, Pages

  Schachter, David ^a   Sang, James C ^a  

^a Columbia University ^*  (United States)

Author keywords

Acetylsalicylate; Endothelium; Guanosine 3',5' cyclic monophosphate; Indomethacin; Prostaglandin H2

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; INDOMETACIN; ISOBUTYLMETHYLXANTHINE; PROSTAGLANDIN H2; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; AORTA ARCH; ARTICLE; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 33751289750     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.273.3.h1478     Document Type: Article

References (14)

1. Abbott, R. E., and D. Schachter. Regional differentiation in rat aorta: L-arginine metabolism and cGMP content in vitro. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H2287-H2295, 1994.
2. Amer, M. S., and W. E. Kreigbaum. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure-activity relationships and possible role in drug development. J. Pharm. Sci. 64: 1-37, 1975.
3. 1. Exp. Cell Res. 75: 518-521, 1972.
4. Beatty, C. H., R. M. Bocek, M. K. Young, and M. J. Noyy. Effect of indomethacin on cyclic AMP phosphodiesterase activity in myometrium from pregnant rhesus monkeys. Prostaglandins 11: 713-725, 1976.
5. Beltman, J., W. K. Sonnenburg, and J. A. Beavo. The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol. Cell. Biochem. 127/128: 239-253, 1993.
6. 2 on some isolated smooth muscle preparations. Br. J. Pharmacol. 73: 773-778, 1981.
7. Eckly, A. E., and C. Lugnier. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br. J. Pharmacol. 113: 445-450, 1994.
8. Furchgott, R. F. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24: 175-197, 1984.
9. Gow, B. S. Circulatory correlates: vascular impendance, resistance and capacity. In: Handbook of Physiology. The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 14, p. 353-408.
10. Hallock, P., and I. C. Benson. Studies on the elastic properties of human isolated aorta. J. Clin. Invest. 16: 595-602, 1937.
11. Ignarro, L. J. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30: 535-560, 1990.
12. Imura, T., K. Yamamoto, K. Kanamori, T. Mikami, and H. Yasuda. Non-invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc. Res. 20: 208-214, 1986.
13. Ishikawa, Y., and D. S. Newcombe. Epiphyseal cartilage cyclic nucleotide phosphodiesterase: partial purification and kinetic characteristics of multiple enzymes. Proc. Soc. Exp. Biol. Med. 152: 105-110, 1976.
14. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertension 15: 475-481, 1990.